Time slot's time in Taipei (GMT+8)
- 2023/10/14
- Room 101
- Type: Physical(Eng)
- SECC 1014
- TIME
- TOPIC
- SPEAKER
- MODERATOR
- 13:30-14:10
- New Trends of the Treatment of Aortic Diseases
- SPEAKER:
陳哲伸(Jer-Shen Chen)
Taiwan (台灣)
- MODERATOR:
- Dr. 陳哲伸(Jer-Shen Chen)
- Department director
- Department of Cardiovascular Surgery, Far Eastern Memorial Hospital
Biography:
2020 ~ now Department director,Department of Cardiovascular Surgery,
Far Eastern Memorial Hospital
2019 ~ now Clinical associate professor ,Department of Surgery, National Yang-Ming-Chiao-Tung University
2012 ~ 2020 Director of Vascular Surgery, FEMH
2020 ~ now Department director,Department of Cardiovascular Surgery,
Far Eastern Memorial Hospital
2019 ~ now Clinical associate professor ,Department of Surgery, National Yang-Ming-Chiao-Tung University
2012 ~ 2020 Director of Vascular Surgery, FEMH
Abstract:
The aortic stent graft dramatically changes the treatment policy of the aortic diseases, including aneurysm and dissection.
The case number of open surgical grafting for aortic diseases without involvement of ascending aorta is decreasing.
Endovascular treatment provided shorter operation time and significantly lower surgical risk.
For acute type A aortic dissection, traditionally, ascending aorta grafting is the gold standard of treatment. Although the AsAo grafting could save the patient's life. Residual arch and descending aorta dissection posed difficult future problems.
With the aortic stent graft, the arch replacement could be done much easier. Currently, for young patients without significant pre-op malperfusion, we can safely replace the aortic arch with concurrent antegrade endografting. Maximizing aortic repair can be achieved without significantly increasing surgical risk. The future re-intervention or re-operation rate could be reduced.
The aortic stent graft dramatically changes the treatment policy of the aortic diseases, including aneurysm and dissection.
The case number of open surgical grafting for aortic diseases without involvement of ascending aorta is decreasing.
Endovascular treatment provided shorter operation time and significantly lower surgical risk.
For acute type A aortic dissection, traditionally, ascending aorta grafting is the gold standard of treatment. Although the AsAo grafting could save the patient's life. Residual arch and descending aorta dissection posed difficult future problems.
With the aortic stent graft, the arch replacement could be done much easier. Currently, for young patients without significant pre-op malperfusion, we can safely replace the aortic arch with concurrent antegrade endografting. Maximizing aortic repair can be achieved without significantly increasing surgical risk. The future re-intervention or re-operation rate could be reduced.